People In Brief
This article was originally published in The Gray Sheet
Executive Summary
FDA appoints Toigo to replace Wood: FDA's Office of Special Health Issues Director Theresa Toigo is named acting director of the Office of Women's Health. Toigo, who has worked at the Center for Drug Evaluation & Research, the Center for Biologics Evaluation & Research and the Office of the Commissioner since 1984, will bring her experience as a liaison with patients and advocacy groups to her new post, where she will ensure that regulation remains "gender sensitive and responsive" and "work to correct any identified gender disparities in drug, device and biologics testing," according to a Sept. 16 release. On Aug. 31, former Women's Health Director Susan Wood resigned in protest over the agency's handling of Barr's Plan B emergency contraceptive (1"The Gray Sheet" Sept. 5, 2005, p. 6)...